Table 1.
Effect of PRP concentrations and extender types on equilibrated sperm quality (mean ± SEM)
| Extender | PRP (%) | N | Progressive motility (%) | Viability (%) | Abnormality (%) |
|---|---|---|---|---|---|
| OptiXcell® A | 0% | 48 | 57.17 ± 1.20b | 79.67 ± 1.56b | 13.83 ± 0.95a |
| 5% | 48 | 60.33 ± 2.57ab | 82.50 ± 1.28ab | 11.83 ± 1.25a | |
| 10% | 48 | 64.33 ± 2.04a | 85.50 ± 1.23a | 7.50 ± 0.99b | |
| 15% | 48 | 62.83 ± 1.74ab | 84.33 ± 1.33a | 8.33 ± 0.96b | |
| Tris egg yolk-based B | 0% | 48 | 54.50 ± 0.76c | 78.17 ± 1.60b | 15.67 ± 1.33a |
| 5% | 48 | 56.67 ± 0.80bc | 79.83 ± 1.25ab | 13.17 ± 0.98ab | |
| 10% | 48 | 61.50 ± 1.88a | 82.83 ± 1.51a | 10.83 ± 1.14b | |
| 15% | 48 | 60.17 ± 1.45ab | 81.77 ± 0.98ab | 10.33 ± 0.56b |
N = 48 ejaculates. Within columns, values with different superscripts differ significantly for each parameter (P < 0.05)
Within the same column, means bearing a, b, and c differ among PRP concentrations (0%, 5%, 10% and 15%) within the same extender (OptiXcell® or Tris egg yolk-based). A and B differ between extender types (OptiXcell® or Tris egg yolk-based), at the same PRP concentrations (0%, 5%, 10% and 15%)
PRP, Platelet-rich plasma